SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001640334-20-002851
Filing Date
2020-11-17
Accepted
2020-11-16 17:59:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G clcs_sc13g.htm SC 13G 42071
  Complete submission text file 0001640334-20-002851.txt   43629
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Subject) CIK: 0001569340 (see all company filings)

IRS No.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91841 | Film No.: 201318721
SIC: 2834 Pharmaceutical Preparations

Mailing Address P.O. BOX 95 REHOVOT L3 7610002
Business Address P.O. BOX 95 REHOVOT L3 7610002 972-8-9470739
Yeda Research & Development Co., Ltd. (Filed by) CIK: 0001832288 (see all company filings)

IRS No.: 980455718 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G